Study

Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris. – Cost Effective Supplements

Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/23786503


Conclusion of this study

No major side effect was encountered by any patient. Skin type is a significant factor in choosing between topical nicotinamide and clindamycin in patients with acne vulgaris.


Supplements analyzed in this study

Vitamin B3

Health conditions analyzed in this study

Acne


Moderately Positive
Vitamin B3


Functions related to this study

Immunity


Moderately Positive
Vitamin B3


Body systems related to this study


Integumentary system
Scroll to top